Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Health Robotics' i.v.STATION robot wins the Area Science Park 3L 3T Innovation Award

Health Robotics today announced the manufacturing, shipment, and subsequent field installation of the first five i.v.STATION post-prototype robots in the United States of America and in Spain within the September to November timeframe this year; concurrently, Health Robotics also made the announcement of its i.v.STATION robot's winning of the Area Science Park 3L 3T Innovation Award, which is given to the best technology product across all industries.

12 Oct 2009

QRxPharma signs contractual agreement with Patheon

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today a contractual agreement with Patheon to manufacture clinical supplies of QRxPharma's controlled release Dual-Opioid(TM) formulation (MoxDuo(TM)CR). MoxDuo(TM)CR is designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic).

12 Oct 2009

Buehler Motor relocates and expands its U.S. headquarters

Buehler Motor, Inc. (BMI), a leading international provider of mechatronic drive solutions, has relocated and expanded its U.S. headquarters to allow it to better provide its customers in automotive, aerospace, medical devices, office and building automation with the latest advances in green technology.

12 Oct 2009

XTend Medical provides update regarding the BioHarp market potential

XTend Medical, a company specializing in manufacturing and distributing the latest in telemedicine and diagnostic devices, released the following information regarding the BioHarp market potential.

12 Oct 2009

Pieris reports its progress in the development of PRS-050

Pieris AG, the biopharmaceutical company developing Anticalins as a novel class of targeted human protein therapeutics, today reported continued progress in development of its lead therapeutic program for the clinic.

12 Oct 2009

Selexis and Irvine Scientificti to jointly present results of recent collaborative effort

Selexis SA and Irvine Scientific Inc. announced today plans to jointly present results of a recent collaborative effort combining the Selexis SURE Cell Line Development Programs(TM) and the Irvine IS CHO Culture System, demonstrating the rapid production of gram quantities of monoclonal antibodies from stable CHO production cell lines.

12 Oct 2009

Arch Pharmalabs collaborates with Orochem Technologies to manufacture an API in India

Arch Pharmalabs, Ltd., a leading provider of small molecule process R&D and full life-cycle custom synthesis and manufacturing services, announced today it has entered into a strategic partnership with Orochem Technologies, Inc., to manufacture a U.S. innovator’s active pharmaceutical ingredient (API) in late-stage clinical development using Simulated Moving Bed (SMB) technology.

12 Oct 2009

Presentations on efficacy of interferon to combat influenza

Amarillo Biosciences, Inc. (ABI) today announced that Professor Dr. Otto Haller from the Department of Virology, Freiburg University, Germany and Professor Dr. Oliver Planz from the Friedrich Loeffler Institute, Tubingen, Germany gave two separate presentations on the efficacy of interferon to combat influenza.

12 Oct 2009

Art's Way Scientific to build a 6,000 sq. ft. complex for prestigious cancer research center

Art's Way Manufacturing, Inc., announces its wholly owned subsidiary, Art's Way Scientific, Inc. buildingsforscience.com will be providing design, manufacturing and installation of a 6,000 sq. ft. two story laboratory and office building for Lockard Construction, Inc. www.lockardonline.com who is the prime contractor on this complex for a well known, nationally respected cancer research center. The contract is valued at approximately $3 million.

9 Oct 2009

Cantel Medical announces fiscal 2009 fourth-quarter and full-year financial results

CANTEL MEDICAL CORP. reported a 65% increase in net income to $4,279,000, or $0.26 per diluted share, on a 4% increase in sales to a record $66,793,000 for the fourth quarter ended July 31, 2009. This compares with net income of $2,596,000, or $0.16 per diluted share, on sales of $64,281,000 for the fourth quarter ended July 31, 2008.

9 Oct 2009

Medicago receives contract from U.S. Army Research, Development and Engineering Command laboratory

Medicago Inc. (TSX-V: MDG), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has been awarded a proof of concept contract by the U.S. Army Research, Development and Engineering Command laboratory specifically the Edgewood Chemical Biological Center ("ECBC") Research & Technology Directorate.

9 Oct 2009

New soy germ-based ingredient improves menopausal symptoms

SE5-OH containing Natural S-equol, a novel soy germ-based ingredient in a supplement, improved menopausal symptoms, including significantly reducing hot flash frequency by nearly 59 percent, according to a peer-reviewed study in Japanese women.

9 Oct 2009

Ipsen signs exclusive marketing agreement to produce and distribute Braintree's BLI-800 for colonic cleansing

Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical Group and Braintree Laboratories, Inc., a US-based company specializing in the development, manufacturing and marketing of specialty pharmaceuticals, announced today the signature of an agreement for the exclusive manufacturing, marketing and distribution rights of Braintree’s proprietary formulation BLI-800 in colonic cleansing before colonoscopy, the best diagnostic procedure for colorectal cancer screening.

9 Oct 2009

Clemson bioengineer designing new ways to target drugs

Clemson bioengineer Frank Alexis is designing new ways to target drugs and reduce the chances for side effects.

9 Oct 2009

FDA files complaint against Rel's Foods for selling adulterated food products

The U.S. Department of Justice, on behalf of the U.S. Food and Drug Administration, has filed a complaint for permanent injunction against Rel's Foods Inc. (Rel's), of Oakland, Calif., seeking to stop the company from manufacturing, producing, and selling adulterated food products.

9 Oct 2009

Grifols USA to distribute AMDL Diagnostics' DR-70 Onko-Sure cancer test

Radient Pharmaceuticals Corporation, a US-based pharmaceutical company through its wholly-owned subsidiary AMDL Diagnostics, Inc. (ADI) announced today it has entered into an exclusive 5-year marketing and distribution agreement with Grifols USA, LLC.

9 Oct 2009

New high-performance, open fit digital hearing aid from America Hears

America Hears, Inc. (www.AmericaHears.com) introduced a new high-performance, open fit digital hearing aid offering significant value for listeners with mild to moderate hearing loss who need assistance hearing and understanding everyday speech, even in challenging listening environments such as noisy restaurants.

9 Oct 2009

Hospira and Celltrion agree to develop and market eight biogeneric products

Hospira, Inc., the world leader in generic injectable pharmaceuticals, today signed a Business Cooperation Agreement with South Korea-based Celltrion, Inc. and Celltrion Healthcare, Inc. ("Celltrion"), which outlines the business terms of a future distribution agreement for the United States, Europe, Australia, New Zealand and Canada for eight biogeneric products that are currently under development by Celltrion, five of which are incremental to Hospira's pipeline.

9 Oct 2009

CHFA awards two individuals for their contributions in natural and organic products industry

The natural health and organic products industry recognized the achievements of individuals committed to the growth of the sector in an awards presentation at the Canadian Health Food Association's (CHFA), Expo East, October 2-4, 2009.

8 Oct 2009

Xcelience's Xcelodose 120S precision powder micro-dosing system accelerates drug development

Xcelience, a leader in early development services, recognizes that providing access to a third, dedicated Xcelodose® 120S precision powder micro-dosing system in the experimental area enables clients to accelerate drug development with preliminary compound evaluation, earlier go/ no-go decisions and flexible options for experimental studies.

8 Oct 2009

Manufacturing News and Research

Further Reading

Health Robotics' i.v.STATION robot wins the Area Science Park 3L 3T Innovation Award

QRxPharma signs contractual agreement with Patheon

Buehler Motor relocates and expands its U.S. headquarters

XTend Medical provides update regarding the BioHarp market potential

Pieris reports its progress in the development of PRS-050

Selexis and Irvine Scientificti to jointly present results of recent collaborative effort

Arch Pharmalabs collaborates with Orochem Technologies to manufacture an API in India

Presentations on efficacy of interferon to combat influenza

Art's Way Scientific to build a 6,000 sq. ft. complex for prestigious cancer research center

Cantel Medical announces fiscal 2009 fourth-quarter and full-year financial results

Medicago receives contract from U.S. Army Research, Development and Engineering Command laboratory

New soy germ-based ingredient improves menopausal symptoms

Ipsen signs exclusive marketing agreement to produce and distribute Braintree's BLI-800 for colonic cleansing

Clemson bioengineer designing new ways to target drugs

FDA files complaint against Rel's Foods for selling adulterated food products

Grifols USA to distribute AMDL Diagnostics' DR-70 Onko-Sure cancer test

New high-performance, open fit digital hearing aid from America Hears

Hospira and Celltrion agree to develop and market eight biogeneric products

CHFA awards two individuals for their contributions in natural and organic products industry

Xcelience's Xcelodose 120S precision powder micro-dosing system accelerates drug development

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy